Novavax, Inc.

NASDAQ:NVAX   3:59:55 PM EDT
138.61
+1.75 (+1.28%)
5:24:31 PM EDT: $138.10 -0.51 (-0.37%)
Business Deals

Mabion Signs $372 Commercial Scale Production Deal With Novavax

Published: 10/08/2021 06:47 GMT
Novavax, Inc. (NVAX) - Says Signs Commercial Scale Production Deal With Novovax.
Says Total Value of Agreement is $372 Mln.
Says Deal to Run From 2022-2025.
Says Will Produce Antigene for Covid-19 Vaccine.
Says Deal is Unconditional and is Not Dependent on Vaccine Registration Procedures.
Says Deal is to Be Carried Out and Settled on a per Batch Basis for an Agreed Price per Series.
Says Commercial Scale Manufacturing in Gmp Standard to Start in Dec.